Parental willingness to COVID-19 vaccination among 5- to 11-year-old children in Jordan

Author:

Mayyas Fadia1ORCID

Affiliation:

1. Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology , Irbid , Jordan

Abstract

Abstract Objectives Although an emergency approval for Coronavirus Disease 2019 (COVID-19) vaccine was given for 5- to 15-year-old children, there is a public hesitancy to give it for children. This study aimed to investigate parental willingness to COVID-19 vaccine among 5- to 11-year-old children. Methods A cross-sectional study using a self-administered questionnaire was distributed to parents from Jordan through social media and at the paediatric clinics. Key findings Six hundred and sixty-two parents participated. The mean age was 42.3 ± 2.9 years old and 67% of them were mothers. Around 60% of parents had 5- to 11-year-old children, 56% had children under 5 years, and 49.5% had 12- to 18-year-old children. About 89% of parents and 20% of their 12–18 years children had received COVID-19 vaccine. Only 37% of parents thought that COVID-19 vaccines are safe in children. Only 36/399 parents accepted the vaccine for their 5–11 years children and 232/339 rejected it. The acceptance number increased to 171 if the vaccine was a condition for school admission. Potential long-term unknown side effect was the most reported concern. Independent factors correlated with parental willingness to 5–11 years children vaccination were having a high income, having had children vaccinated to influenza vaccine, and trusting information from the government. Whereas concern of side effects was associated with vaccine rejection. Conclusion Vaccine acceptance for 5- to 11-year-old children is a major issue among parents. The current study could assist the policymakers in Jordan to undertake strategies to encourage children vaccination to confine the spread of the pandemic.

Funder

Jordan University of Science and Technology

Publisher

Oxford University Press (OUP)

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference32 articles.

1. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis;Kumar;Diabetes Metab Syndr,2020

2. Covid-19 and the cardiovascular system: a comprehensive review;Azevedo;J Hum Hypertens,2021

3. Kawasaki-like disease: emerging complication during the COVID-19 pandemic;Viner;Lancet,2020

4. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents;Viner;Arch Dis Child,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3